NCT03812991View on ClinicalTrials.gov

The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

September 30, 2022

Study Completion Date

February 28, 2023

Conditions
Pelvic Ring Fractures
Interventions
DRUG

Miacalcin Calcitonin Salmon Nasal Spray

Miacalcin nasal spray is 1 spray (200 International Units) per day administered intranasally, alternating nostrils daily

Trial Locations (1)

65212

University of Missouri Health System, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT03812991 - The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries | Biotech Hunter | Biotech Hunter